Latest S1YK34 news and sentiment

Stryker (SYK) Stock Still Looks Cheap On Its 24% Slide

Stryker has seen its share price slide sharply over the past year, and the question now is whether the current valuation still lines up with the cash the business is expected to generate. For investors watching the stock after recent headlines, the focus has shifted from past returns to whether today's price fairly reflects those underlying cash flows. The stock has fallen 24.5% over the past year, which puts the spotlight on whether that move has brought the valuation closer to what its future cash flows can support. Ongoing manufacturing issues in the peripheral vascular business and the rel

Why Pay More For Stryker When BSX Stock Is On Sale?

Pulmera Appoints Jared Slibeck Chief Commercial Officer

Twenty-year industry veteran in surgical navigation and enabling technology joins Pulmera to spearhead commercial adoption of its CBeam™ 3D Imaging Platform, the first C-Arm Native 3D imaging system. 20-Year Stryker Veteran Jared Slibeck Joins Pulmera as Chief Commercial OfficerJared Slibeck has been named Chief Commercial Officer for Pulmera, effective September 1, 2026. Slibeck will lead the company's commercial strategy and market development as the company brings the CBeam™ 3D Imaging Platform into hospitals and surgery centers across the country. Slibeck joins Pulmera after more than twen

Schedule update: Stryker to participate in the 2026 Wells Fargo Healthcare Conference

Stryker Corporation Portage, Michigan, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2026 Wells Fargo Healthcare Conference on Tuesday, September 8, 2026, at the Encore Boston Harbor, as previously reported. Preston Wells, Vice President, Chief Financial Officer and Nick Mead, Vice President, Investor Relations will now participate in a fireside chat session at 10:15 a.m. (Eastern time). A simultaneous live audio webcast and replay of the session can be accessed at Stryker - Events & Presentations. About Stryker Stryker is a global leader in medical technologies

Stryker (SYK) is Buying ZuriMED. Can FiberLocker Strengthen its Shoulder Portfolio?

Stryker Corporation (NYSE:SYK) signed a definitive agreement to acquire privately held ZuriMED, which would add the commercialized FiberLocker System to its shoulder portfolio upon closing. FiberLocker is designed to reinforce rotator-cuff repairs by strengthening the connection between a surgical patch and tendon tissue. The transaction remains subject to customary closing conditions, while the purchase price and expected financial contribution were not disclosed. The strategic logic is straightforward. Stryker Corporation (NYSE:SYK) can place FiberLocker alongside its existing sports-medicin

Stryker Launches FDA-Cleared Apple Vision Pro Surgical App

Stryker SYK recently announced the successful completion of the first hip arthroscopy procedure using its SportSuite Vision application on Apple Vision Pro at Duke Health. The milestone follows the FDA's De Novo authorization for the application in July, making it the first surgical application approved for intraoperative use with Apple's mixed reality headset. From an investor's perspective, the development reinforces Stryker's push to strengthen its digital surgery portfolio and expand innovation across its Sports Medicine business. Although the launch is unlikely to materially affect near-t

Stryker (SYK) Wins FDA Nod And Completes First Procedure With New Surgery Software

Stryker (NYSE:SYK) received FDA De Novo authorization for its SportSuite Vision software on Apple Vision Pro in a clinical setting. The company reported completion of the first surgical procedure using SportSuite Vision in an operating room environment. The software introduces augmented reality and spatial computing tools into surgical workflows and operating room visualization. The authorization marks a regulatory milestone for Stryker in mixed reality applications for healthcare. This move into augmented reality and spatial computing is part of a wider shift across medical technology and AI

Stryker to add rotator cuff repair tech with ZuriMED buy

Stryker to Acquire ZuriMED to Expand Its Shoulder Care Portfolio

Stryker SYK recently announced a definitive agreement to acquire ZuriMED, developer of the FiberLocker System, a commercialized technology designed for rotator cuff augmentation with increased biomechanical strength. The acquisition is aimed at strengthening Stryker's shoulder portfolio and expanding its ability to support specialists across the continuum of shoulder care. Per Stryker management, ZuriMED's technology addresses an important unmet need for shoulder care. The addition of the FiberLocker System is expected to complement Stryker's existing offerings while reinforcing its focus on a

Stryker introduces first of its kind FDA-authorized surgical application for Apple Vision Pro with hip arthroscopy case at nationally recognized academic medical center

SportSuite Vision brings spatial computing into the operating room, providing surgeons access to critical clinical information Stryker announced the successful completion of the first surgical procedure, a hip arthroscopy, using SportSuite Vision on Apple Vision Pro at a leading academic medical center. Stryker received FDA De Novo authorization for the first surgical application for intraoperative use with Apple Vision Pro, SportSuite Vision. SportSuite Vision brings arthroscopic video, HipCheck, HipMap and CT imaging into a customizable spatial computing environment, helping surgeons access

Stryker (SYK) Stock Looks Like A Bargain Near Fair Value

Stryker stock has delivered a modest total return over the past five years, while the current intrinsic value estimate from a Discounted Cash Flow (DCF) framework suggests the shares trade at a discount to that internal calculation. At the same time, market based valuation multiples point to pricing that is broadly in line with peers, which leaves investors weighing two different valuation signals. Stryker has returned about 23.3% over the past five years, which points to a measured long term outcome rather than a runaway winner or a clear disappointment. The company's ability to grow cash flo

Stryker signs definitive agreement to acquire ZuriMED to enhance its shoulder offering

Stryker Corporation Portage, Mich., USA, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Stryker has signed a definitive agreement to acquire ZuriMED, developer of the FiberLocker System, a commercialized technology that provides a novel approach for rotator cuff augmentation designed for increased biomechanical strength. The acquisition strengthens Stryker's shoulder portfolio, enhancing its ability to support specialists across the continuum of care. The FiberLocker System is a soft tissue augmentation technology designed to reduce the occurrence of a key clinical failure mode in rotator cuff repair, one

Stryker to participate in the 2026 Wells Fargo Healthcare Conference

Stryker Corporation Portage, Michigan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2026 Wells Fargo Healthcare Conference on Tuesday, September 8, 2026, at the Encore Boston Harbor. Preston Wells, Vice President, Chief Financial Officer and Nick Mead, Vice President, Investor Relations will also participate in a fireside chat session at 2:15 p.m. (Eastern time). A simultaneous live audio webcast and replay of the session can be accessed at Stryker - Events & Presentations. About Stryker Stryker is a global leader in medical technologies and, together with our c

US$100 Million Defense Contract Win Might Change The Case For Investing In Stryker (SYK)

Stryker's sales unit in Michigan previously secured a US$100.00 million contract modification from the U.S. Defense Logistics Agency, underscoring its role as a key supplier to government healthcare and logistics systems. This award highlights the importance of stable government contracting as a complement to Stryker's hospital and surgical product revenue mix. We'll now examine how this sizable Defense Logistics Agency contract influences Stryker's investment narrative, particularly its government-linked revenue visibility. Rare earth metals are the new gold rush. Find out which 28 stocks are

Here's Why You Should Hold Stryker Stock in Your Portfolio for Now

Stryker SYK entered 2026 facing an unexpected cyber disruption, yet underlying demand, robotics adoption and international momentum remained strong. While a robust capital pipeline and active acquisition strategy support long-term growth, execution risks tied to recovery efforts, margin pressures and expanding exposure to new markets could shape the company's performance over the coming quarters. This Zacks Rank #3 (Hold) company's shares have lost 6.7% so far this year compared with the industry's 15.2% decline. The S&P 500 Index has appreciated 11.2% in the same time frame. Stryker is a glob